SI1071418T1 - New treatments for nervous disorders - Google Patents

New treatments for nervous disorders

Info

Publication number
SI1071418T1
SI1071418T1 SI9930684T SI9930684T SI1071418T1 SI 1071418 T1 SI1071418 T1 SI 1071418T1 SI 9930684 T SI9930684 T SI 9930684T SI 9930684 T SI9930684 T SI 9930684T SI 1071418 T1 SI1071418 T1 SI 1071418T1
Authority
SI
Slovenia
Prior art keywords
new treatments
nervous disorders
reboxetine
noradrenaline reuptake
new
Prior art date
Application number
SI9930684T
Other languages
English (en)
Slovenian (sl)
Inventor
Adriana Dubini
John Michael Mccall
Duncan Paul Taylor
Voigtlander Philip F. Von
Erik Ho Fong Wong
Original Assignee
Pharmacia Italia S.P.A.
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia S.P.A., Pharmacia & Upjohn Company filed Critical Pharmacia Italia S.P.A.
Publication of SI1071418T1 publication Critical patent/SI1071418T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Mobile Radio Communication Systems (AREA)
SI9930684T 1998-04-13 1999-04-02 New treatments for nervous disorders SI1071418T1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11
EP99918423A EP1071418B1 (fr) 1998-04-13 1999-04-02 Nouveaux traitements pour troubles nerveux
PCT/US1999/004288 WO1999052518A2 (fr) 1998-04-13 1999-04-02 Nouveaux traitements pour troubles nerveux

Publications (1)

Publication Number Publication Date
SI1071418T1 true SI1071418T1 (en) 2005-04-30

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930684T SI1071418T1 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders

Country Status (25)

Country Link
US (1) US6391876B1 (fr)
EP (1) EP1071418B1 (fr)
JP (1) JP2002511408A (fr)
KR (1) KR100555279B1 (fr)
CN (1) CN1197569C (fr)
AT (1) ATE277617T1 (fr)
AU (1) AU755612B2 (fr)
BR (1) BR9909476A (fr)
CA (1) CA2320722A1 (fr)
DE (1) DE69920679T2 (fr)
DK (1) DK1071418T3 (fr)
EA (1) EA003546B1 (fr)
ES (1) ES2228035T3 (fr)
HU (1) HUP0101748A3 (fr)
IL (1) IL138887A0 (fr)
IT (1) IT1305322B1 (fr)
NO (1) NO20005131L (fr)
NZ (1) NZ507693A (fr)
PL (1) PL194039B1 (fr)
PT (1) PT1071418E (fr)
SI (1) SI1071418T1 (fr)
SK (1) SK14482000A3 (fr)
TR (1) TR200002970T2 (fr)
WO (1) WO1999052518A2 (fr)
ZA (1) ZA200004480B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
ES2242175T3 (es) 1999-07-01 2005-11-01 PHARMACIA & UPJOHN COMPANY LLC (s,s)-reboxetina para tratar la fibromialgia y otros trastornos somatoformes.
EP1459749B1 (fr) * 1999-07-01 2005-10-05 Pharmacia & Upjohn Company LLC (S,S)-réboxétine pour traiter l'incontinence
AU2002217757A1 (en) * 2000-11-15 2002-05-27 Eli Lilly And Company Treatment of anxiety disorders
CN101298440A (zh) * 2002-06-17 2008-11-05 辉瑞意大利公司 瑞波西汀的药物盐
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
EP0919234A3 (fr) 1997-10-17 1999-08-25 Eli Lilly And Company Potentialisation d'un médicament par la moxonidine

Also Published As

Publication number Publication date
NO20005131D0 (no) 2000-10-12
IL138887A0 (en) 2001-11-25
HUP0101748A3 (en) 2001-12-28
HUP0101748A2 (hu) 2001-11-28
IT1305322B1 (it) 2001-05-04
CA2320722A1 (fr) 1999-10-21
CN1293569A (zh) 2001-05-02
ES2228035T3 (es) 2005-04-01
PT1071418E (pt) 2004-12-31
WO1999052518A2 (fr) 1999-10-21
CN1197569C (zh) 2005-04-20
NO20005131L (no) 2000-10-12
PL194039B1 (pl) 2007-04-30
KR100555279B1 (ko) 2006-03-03
KR20010042641A (ko) 2001-05-25
ZA200004480B (en) 2002-04-24
JP2002511408A (ja) 2002-04-16
EP1071418A2 (fr) 2001-01-31
EA200001058A1 (ru) 2001-04-23
PL346294A1 (en) 2002-01-28
SK14482000A3 (sk) 2001-08-06
DE69920679T2 (de) 2006-03-02
US6391876B1 (en) 2002-05-21
ITMI980870A1 (it) 1999-10-23
BR9909476A (pt) 2000-12-19
AU755612B2 (en) 2002-12-19
TR200002970T2 (tr) 2001-01-22
DE69920679D1 (de) 2004-11-04
AU3635199A (en) 1999-11-01
ATE277617T1 (de) 2004-10-15
DK1071418T3 (da) 2005-01-03
EP1071418B1 (fr) 2004-09-29
WO1999052518A3 (fr) 1999-12-02
NZ507693A (en) 2003-08-29
EA003546B1 (ru) 2003-06-26

Similar Documents

Publication Publication Date Title
PL346294A1 (en) New treatments for nervous disorders
MY134110A (en) Combinations of reboxetine and neuroleptic agents
PL321273A1 (en) Method of treating disorders associated with occurence of approsexia/motorial hyperecxitability
ES2166110T3 (es) Agonistas no alostericos de gabaa para tratar trastornos del sueño.
WO2001062236A3 (fr) Nouvelles combinaisons medicamenteuses
HK1091418A1 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
PT739212E (pt) Utilizacao de interleucina-12 para a prevencao de doenca causada pela reaccao do enxerto contra o hospedeiro
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
ATE329588T1 (de) Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns- erkrankungen
PL402987A1 (pl) Enancjomer (1S, 2R) milnacypranu do wytwarzania leku
BR0208040A (pt) Derivados de benzofuran-2-carboxamidas substituìdas
MY143278A (en) Treatment of neurotic disorders.
ES2118569T3 (es) Procedimiento para la regeneracion de un catalizador.
MY136367A (en) Treatment of cognitive failure
PL345351A1 (en) New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol
EP0756869A3 (fr) Utilisation de la duloxétine ou de N-alkyl-3-phényl-(2-alkylthiophénoxy)-propylamines pour le traitement des troubles de l'attention et de l'hyperactivité
BR0115301A (pt) Uso de um inibidor seletivo da recaptação de norepinefrina
PL337996A1 (en) Method of treating and preventing cardiac disorders using a selective serotonin reuptake inhibitor (ssri)
EA199900220A1 (ru) Терапевтическое лечение сексуальных дисфункций
ZA991638B (en) Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders and autism.
PT1282414E (pt) Compostos derivados de felbamato para o tratamento da dor neuropatica
WO2004045508A3 (fr) Utilisation d'inhibiteurs de pde4 comme traitement d'appoint de troubles psychiatriques
ECSP992873A (es) Metodo para tratar desordenes compulsivos, obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso, y autismo (caso cn0823)